Detailed Information
Cited 10 time in 
Cited 10 time in 
Cited 10 time in
Metadata Downloads
Comparison of MOG and AQP4 antibody seroprevalence in Korean adults with inflammatory demyelinating CNS diseases
- Authors
- Hyun, Jae-Won; Lee, Hye Lim; Jeong, Woo Kyo; Lee, Hye Jung; Shin, Jong Hwa; Min, Ju-Hong; Kim, Byoung Joon; Kim, Seung Woo; Shin, Ha Young; Oh, Jeeyoung; Kim, Woojun; Shin, Hyun-June; Oh, Sun-Young; Kim, Hyunjin; Lim, Young-Min; Huh, So-Young; Cho, Eun Bin; Nam, Tai-Seung; Lee, Seung-Han; Kim, Sun-Young; Kang, Sa-Yoon; Han, Suk Geun; Sohn, Eun Hee; Baek, Seol-Hee; Kim, Byung-Jo; Lee, Sang-Soo; Seok, Jin Myoung; Hong, Yoon-Ho; Oh, Seong-il; Kim, Jong Kuk; Shin, Kyong Jin; Kwon, Ohyun; Cho, Joong-Yang; Bae, Jong Seok; Kim, So Yeon; Kim, Yeseul; Lee, Min Young; Kim, Su-Hyun; Kim, Ho Jin
- Issue Date
- May-2021
- Publisher
- SAGE PUBLICATIONS LTD
- Keywords
- Aquaporin-4; myelin oligodendrocyte glycoprotein; prevalence; adult
- Citation
- MULTIPLE SCLEROSIS JOURNAL, v.27, no.6, pp 964 - 967
- Pages
- 4
- Indexed
- SCIE
SCOPUS
- Journal Title
- MULTIPLE SCLEROSIS JOURNAL
- Volume
- 27
- Number
- 6
- Start Page
- 964
- End Page
- 967
- ISSN
- 1352-4585
1477-0970
- Abstract
- We aimed to compare seroprevalence of anti-myelin oligodendrocyte glycoprotein (MOG) and anti-aquaporin-4 (AQP4) antibodies in Korean adults with inflammatory demyelinating diseases (IDDs) of the central nervous system (CNS), based on a multicenter nationwide database. Sera were analyzed using a live cell-based assay for MOG and AQP4 antibodies. Of 586 Korean adults with IDDs of the CNS, 36 (6.1%) and 185 (31.6%) tested positive for MOG and AQP4 antibodies, respectively. No participant showed double positivity. Seroprevalence of MOG antibodies was about five times lower than that of AQP4 antibodies in a large cohort of Korean adults with IDDs of the CNS.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Medicine > Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.